Company release, 17 November 2022 at 6.20 p.m. (EET)

Nightingale Health Plc changes the publication date of the half-year financial report for the period 1 July–31 December 2022. The report will be published on 23 March 2023. The previously announced publication date was 2 March 2023.


For further information:
CEO Teemu Suna,

Certified Adviser:
Oaklins Merasco Ltd, tel. +358 9 6129 670

About Nightingale Health
Nightingale Health is The Preventative Health Company. Staying healthy is one of the top priorities in human life. Our health has a profound impact on our quality of life, and it’s also strongly connected to the lives of those close to us. Nightingale Health enables prevention by combining the power of our in-house developed, advanced blood analysis technology with unprecedented access to global health repositories and world-leading medical research. With this combination, we go beyond the traditional healthcare and wellbeing tools: We provide the scientific connection to multiple health and disease outcomes and the ability to predict future healthy years.